New England Journal of Medicine · 1969 · 131 citations · 9 references
MedicineNephrologyPharmacologyClinical PharmacologyRenal PathophysiologyRenal PharmacotherapyAcute Kidney InjuryGlomerular PathophysiologyRenal DiseaseFibrin Clot FormationGlomerular Capillary DamageGlomerular Capillary InjuryHemorrhagic ManifestationsHemorrhagic PresentationRenal Failure ManagementThrombosis In Hemolytic Disorders
WITH increased awareness of the hemorrhagic syndromes produced by spontaneous intravascular coagulation or fibrinolysis, there has been increased use of epsilon-amino caproic acid (EACA, Amicar) as a therapeutic agent. This, in turn, has led to recognition of a number of its toxic side effects.1 , 2 Hypotension, one of its known side effects,1 , 2 could produce acute tubular necrosis and thus precipitate acute renal failure. Intraureteral clot formation, reported after the use of EACA for treatment of hematuria in patients with hemophilia,1 2 3 if bilateral could also result in anuria and renal failure. The following case illustrates the development of oliguria and renal failure . . .
9
Thrombotic thrombocytopenic purpura with acute anuric renal failure
George Dunea, Robert C. Muehrcke, Satoru Nakamoto et al. · The American Journal of Medicine · 1966 · 47 citations
Medicine, Hematology, Nephrology +9